Rivaroxaban sets new standards for oral anticoagulation therapy

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1572, 2007-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim Schott Gisela

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite

Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty

By Borris Lars C

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 1083-1088

Informa Healthcare

Access to resources Recommend Favorite

For a sizeable proportion of patients who require oral anticoagulation therapy, self-management is reliable in those with appropriate training

Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Anticoagulation Therapy in Children

By Ronghe M.D. Halsey C.

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 803-820

Adis International

Access to resources Recommend Favorite

Oral rivaroxaban a worthwhile choice for VTE prevention in US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite